PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,088,000 | -7.5% | 112,143 | -2.7% | 0.00% | 0.0% |
Q2 2018 | $1,176,000 | -32.3% | 115,282 | -13.8% | 0.00% | -50.0% |
Q1 2018 | $1,738,000 | -27.4% | 133,682 | 0.0% | 0.00% | -33.3% |
Q4 2017 | $2,393,000 | -28.7% | 133,682 | 0.0% | 0.00% | -25.0% |
Q3 2017 | $3,355,000 | +4.1% | 133,682 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $3,222,000 | +6.7% | 133,682 | -14.8% | 0.00% | 0.0% |
Q1 2017 | $3,020,000 | +25.0% | 156,858 | 0.0% | 0.00% | +33.3% |
Q4 2016 | $2,416,000 | – | 156,858 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,600,410 | $16,279,000 | 2.44% |
Abingworth LLP | 1,041,131 | $6,517,000 | 2.23% |
Telemetry Investments, L.L.C. | 194,789 | $1,219,000 | 2.06% |
AIGH Capital Management LLC | 749,608 | $4,692,000 | 1.91% |
Trellus Management Company, LLC | 340,000 | $2,128,000 | 1.76% |
Bruce & Co., Inc. | 929,312 | $5,817,000 | 1.12% |
Worth Venture Partners, LLC | 191,093 | $1,196,000 | 0.95% |
GENERAL AMERICAN INVESTORS CO INC | 1,000,751 | $6,265,000 | 0.62% |
Weil Company, Inc. | 104,907 | $657,000 | 0.39% |
NEXPOINT ASSET MANAGEMENT, L.P. | 140,020 | $877,000 | 0.29% |